Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05473130 · ClinicalTrials.gov registry record
Breethe Abiomed Recovery RegisTry (BART)
A clinical trial, sponsored by Abiomed.
- Completed
- Registry status
- 48
- Enrollment target
NCT05473130 is a clinical trial that has completed, run by Abiomed. The registered enrollment target is 48 participants.
The verdict
NCT05473130 has completed, sponsored by Abiomed.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
Interventions
- DEVICE Breethe Oxy-1 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2024-04-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05473130
The ClinicalTrials.gov registry entry for NCT05473130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breethe Oxy-1 System is the first listed.
NCT05473130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05473130 about?
NCT05473130 is a clinical study titled "Breethe Abiomed Recovery RegisTry (BART)". The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
What is the current status of trial NCT05473130?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2021-03-31. Estimated completion is 2024-04-02.
What interventions are being tested in trial NCT05473130?
The interventions under investigation include: Breethe Oxy-1 System (DEVICE).
Who is sponsoring clinical trial NCT05473130?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.